Faraone, Stephen V. http://orcid.org/0000-0002-9217-3982
Newcorn, Jeffrey H.
Cipriani, Andrea http://orcid.org/0000-0001-5179-8321
Brandeis, Daniel
Kaiser, Anna
Hohmann, Sarah
Haege, Alexander
Cortese, Samuele
Article History
Received: 27 January 2021
Revised: 26 March 2021
Accepted: 14 April 2021
First Online: 10 May 2021
Compliance with ethical standards
:
: In the past year, SVF received income, potential income, travel expenses continuing education support and/or research support from Arbor, Genomind, Ironshore, KemPharm/Corium, Ondosis, Otsuka, Rhodes, Shire/Takeda, Supernus, and Tris. With his institution, he has US patent US20130217707 A1 for the use of sodium–hydrogen exchange inhibitors in the treatment of ADHD. He also receives royalties from books published by Guilford Press: Straight Talk about Your Child’s Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is Program Director of ExternalRef removed. In the past year, JHN is/has been an advisor and/or consultant for Adlon Therapeutics, Arbor, Cingulate Therapeutics, Corium, Eisai, Lundbeck, Medice, Myriad Neuroscience, NLS, OnDosis, Rhodes, Shire/Takeda, and Supernus. He has received research support from the National Institute on Drug Abuse (NIDA), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Adlon, Shire and Supernus. He also has received speaker fees from Shire/Takeda for disease-state presentations, and served as a consultant for the US National Football League. AC has received research and consultancy fees from INCiPiT (Italian Network for Paediatric Trials), CARIPLO Foundation and Angelini Pharma. DB serves as an unpaid scientific consultant for an EU-funded neurofeedback trial. AK reports no financial disclosures. SH has no financial disclosures. AH received conference support, speaker’s fee and/or served in an advisory role for Shire/Takeda and Lily. He was involved as investigator in clinical trials by Shire, Janssen-Cilag, Otsuka, Sunovion, Servier, Lundbeck, Takeda, Nuvelution, Gedeon Richter, and Emalex. The present work is unrelated to the above relationships. SC declares reimbursement for travel and accommodation expenses from the Association for Child and Adolescent Central Health (ACAMH) in relation to lectures delivered for ACAMH, Canadian ADHD Resource Alliance (CADDRA), British Association of Psychopharmacology (BAP), and from Healthcare Convention for educational activity on ADHD.